Atom | NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)

Funding Amounts: Up to $3,000,000 total over 3 years (no more than $1,500,000 per year); third-party matching funds required.

Summary: Supports SBIR Phase II awardees in pre-clinical research to bridge the funding gap to commercialization, emphasizing third-party investment and partnerships.

Key Information: Clinical trials are not allowed; strong third-party funding is expected and required for most applicants.

NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)

Sign in to see full grant listing